Controlling the Mdm2-Mdmx-p53 Circuit
The p53 tumor suppressor is a key protein in maintaining the integrity of the genome by inducing either cell cycle arrest or apoptosis following cellular stress signals. Two human family members, Mdm2 and Mdmx, are primarily responsible for inactivating p53 transcription and targeting p53 protein fo...
Saved in:
Published in | Pharmaceuticals Vol. 3; no. 5; pp. 1576 - 1593 |
---|---|
Main Authors | , , , |
Format | Journal Article Book Review |
Language | English |
Published |
Switzerland
MDPI AG
18.05.2010
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The p53 tumor suppressor is a key protein in maintaining the integrity of the genome by inducing either cell cycle arrest or apoptosis following cellular stress signals. Two human family members, Mdm2 and Mdmx, are primarily responsible for inactivating p53 transcription and targeting p53 protein for ubiquitin-mediated degradation. In response to genotoxic stress, post-translational modifications to p53, Mdm2 and Mdmx stabilize and activate p53. The role that phosphorylation of these molecules plays in the cellular response to genotoxic agents has been extensively studied with respect to cancer biology. In this review, we discuss the main phosphorylation events of p53, Mdm2 and Mdmx in response to DNA damage that are important for p53 stability and activity. In tumors that harbor wild-type p53, reactivation of p53 by modulating both Mdm2 and Mdmx signaling is well suited as a therapeutic strategy. However, the rationale for development of kinase inhibitors that target the Mdm2-Mdmx-p53 axis must be carefully considered since modulation of certain kinase signaling pathways has the potential to destabilize and inactivate p53. |
---|---|
AbstractList | The p53 tumor suppressor is a key protein in maintaining the integrity of the genome by inducing either cell cycle arrest or apoptosis following cellular stress signals. Two human family members, Mdm2 and Mdmx, are primarily responsible for inactivating p53 transcription and targeting p53 protein for ubiquitin-mediated degradation. In response to genotoxic stress, post-translational modifications to p53, Mdm2 and Mdmx stabilize and activate p53. The role that phosphorylation of these molecules plays in the cellular response to genotoxic agents has been extensively studied with respect to cancer biology. In this review, we discuss the main phosphorylation events of p53, Mdm2 and Mdmx in response to DNA damage that are important for p53 stability and activity. In tumors that harbor wild-type p53, reactivation of p53 by modulating both Mdm2 and Mdmx signaling is well suited as a therapeutic strategy. However, the rationale for development of kinase inhibitors that target the Mdm2-Mdmx-p53 axis must be carefully considered since modulation of certain kinase signaling pathways has the potential to destabilize and inactivate p53. |
Author | Lehman, Jason A Batuello, Christopher N Waning, David L Mayo, Lindsey D |
AuthorAffiliation | 2 Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Drive, MS 4053, Indianapolis, IN 46202, USA 1 Herman B Wells Center for Pediatric Research, 980 West Walnut, Walther Hall R3-C548, Indianapolis, IN 46202, USA |
AuthorAffiliation_xml | – name: 2 Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Drive, MS 4053, Indianapolis, IN 46202, USA – name: 1 Herman B Wells Center for Pediatric Research, 980 West Walnut, Walther Hall R3-C548, Indianapolis, IN 46202, USA |
Author_xml | – sequence: 1 givenname: David L surname: Waning fullname: Waning, David L organization: Herman B Wells Center for Pediatric Research, 980 West Walnut, Walther Hall R3-C548, Indianapolis, IN 46202, USA – sequence: 2 givenname: Jason A surname: Lehman fullname: Lehman, Jason A – sequence: 3 givenname: Christopher N surname: Batuello fullname: Batuello, Christopher N – sequence: 4 givenname: Lindsey D surname: Mayo fullname: Mayo, Lindsey D |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20651945$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkU1r3DAQhkVJaT7aQ_9AWQiF9uBmRh-WdQmEpR-BlF7Ss5Cl0a4Xr7WR7ZD--6rddEl6kcTo4WFm3lN2NKSBGHuL8EkIAxe7tQCFStcv2AlKLquGS3305H3MTsdxA6A0SnzFjjnUCo1UJ-z9Mg1TTn3fDavFtKbF97DlVTkeqp0Si2WX_dxNr9nL6PqR3jzeZ-znl8-3y2_VzY-v18urm8rL2kyVkBHAhNZLw0EpoQJyFSSS1sgjGhB1IwnBYKxjS6VufI2CpHPGSO7EGbvee0NyG7vL3dblXza5zv4tpLyyLk-d78kGHzxS0EDCyxigrV2rPQeK3MjooLgu967d3G4peCpzuv6Z9PnP0K3tKt1bbkAbqIvgw6Mgp7uZxsluu9FT37uB0jxabISSGoRpCnr-H7pJcx7KqiwqrrRuJGKhPu4pn9M4ZoqHZhDsnyDtIcjCvnva_YH8l5z4Da7yl4c |
CitedBy_id | crossref_primary_10_1155_2013_358980 crossref_primary_10_1074_jbc_M110_214155 crossref_primary_10_1016_j_gene_2016_08_053 crossref_primary_10_1016_j_lfs_2015_12_047 crossref_primary_10_1074_jbc_M110_217620 crossref_primary_10_1002_med_20236 crossref_primary_10_1074_jbc_M110_183012 crossref_primary_10_1101_gad_212258_112 crossref_primary_10_1371_journal_pone_0029073 crossref_primary_10_18632_oncotarget_22320 crossref_primary_10_1016_j_yexcr_2011_03_001 crossref_primary_10_1111_febs_16433 crossref_primary_10_3390_ph16101354 crossref_primary_10_1021_ml200276j crossref_primary_10_1016_j_bbamcr_2013_05_022 crossref_primary_10_18632_oncotarget_443 crossref_primary_10_1007_s13238_010_0140_9 crossref_primary_10_1016_j_bcp_2011_07_001 |
Cites_doi | 10.3748/wjg.v10.i2.155 10.1128/MCB.22.17.6170-6182.2002 10.1074/jbc.M208593200 10.1038/nrc2716 10.1016/0092-8674(92)90644-R 10.1038/nrc2559 10.1158/1535-7163.1651.3.12 10.1158/0008-5472.CAN-08-0763 10.1128/MCB.25.15.6509-6520.2005 10.1021/jm050444b 10.1007/s00280-005-0181-6 10.1093/emboj/cdg133 10.1101/gad.14.3.289 10.1074/jbc.M002674200 10.1074/jbc.M809211200 10.1038/sj.onc.1209671 10.4161/auto.5.2.7361 10.1056/NEJM199907153410306 10.1038/nrc1011 10.1128/MCB.19.3.1751 10.1038/542 10.1038/sj.emboj.7600812 10.1038/sj.onc.1201541 10.1158/0008-5472.CAN-03-3403 10.1128/MCB.00555-06 10.1016/j.semcancer.2009.10.005 10.1016/S0021-9258(17)37680-9 10.1073/pnas.251194298 10.1021/np049808d 10.1038/387299a0 10.1074/jbc.274.18.12229 10.1038/sj.onc.1203130 10.1093/emboj/cdf384 10.1038/362857a0 10.1101/gad.886901 10.1093/emboj/20.7.1630 10.1124/jpet.105.084145 10.1158/1535-7163.MCT-08-0492 10.1038/onc.2009.510 10.1007/s10637-007-9090-3 10.1158/0008-5472.CAN-05-4275 10.1038/nm0596-561 10.1016/S0014-5793(99)01647-6 10.1038/nrm2147 10.1634/theoncologist.9-suppl_3-10 10.1038/ncb715 10.1074/jbc.M003485200 10.1073/pnas.95.26.15608 10.1038/387520a0 10.1038/nature05541 10.1038/nrc1455 10.1016/j.cell.2004.11.022 10.1158/0008-5472.CAN-04-2181 10.1126/science.1095920 10.1016/S0014-5793(00)01850-0 10.1126/science.1062538 10.1038/nature03097 10.1128/MCB.00562-06 10.1016/j.cell.2006.12.007 10.1038/ncb714 10.1128/MCB.23.14.4939-4947.2003 10.1038/sj.emboj.7601032 10.1038/387296a0 10.1128/MCB.25.21.9608-9620.2005 10.1038/sj.bjc.6603170 10.1074/jbc.M306938200 10.1016/S1097-2765(04)00123-6 10.1002/ijc.11282 10.1021/bi992454i 10.1016/j.jmb.2010.03.023 10.1038/sj.bjc.6603331 10.1126/science.1099480 10.1038/35044005 10.1586/14737140.4.6.1113 10.1074/jbc.M005401200 10.1158/1535-7163.MCT-09-0519 10.1016/S0014-5793(97)01480-4 10.1016/S0092-8674(00)80416-X 10.1056/NEJM200104053441404 10.1021/jm060727j 10.1002/j.1460-2075.1996.tb00919.x 10.1038/35103059 10.1128/MCB.21.8.2743-2754.2001 10.1016/j.cell.2009.04.037 10.1038/nrc2012 10.1073/pnas.96.26.14973 10.1158/0008-5472.CAN-04-2727 10.1042/bj3550347 10.1056/NEJMoa011573 10.1038/emboj.2009.294 10.1016/j.bmcl.2007.12.037 10.1074/jbc.275.13.9278 10.1074/jbc.M103170200 10.1073/pnas.0408283102 10.1016/S0092-8674(00)81774-2 10.1038/358080a0 10.1056/NEJMra013339 10.1016/j.cell.2009.04.050 10.1186/1476-4598-5-76 10.1101/gad.13.2.152 10.1093/emboj/18.24.7002 10.1016/j.ccr.2009.05.008 10.1038/sj.onc.1207176 10.1038/376785a0 10.1038/sj.onc.1208615 |
ContentType | Journal Article Book Review |
Copyright | Copyright MDPI AG 2010 2010 by the authors; licensee MDPI, Basel, Switzerland. 2010 |
Copyright_xml | – notice: Copyright MDPI AG 2010 – notice: 2010 by the authors; licensee MDPI, Basel, Switzerland. 2010 |
DBID | NPM AAYXX CITATION 3V. 7XB 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO GNUQQ GUQSH M2O MBDVC PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.3390/ph3051576 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea ProQuest Central Student Research Library Prep Research Library Research Library (Corporate) Publicly Available Content (ProQuest) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Research Library ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1424-8247 |
EndPage | 1593 |
ExternalDocumentID | oai_doaj_org_article_dcdc1ed70e3c4fd0b6ab7c20ef294fa0 3307079151 10_3390_ph3051576 20651945 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA109262 – fundername: NCI NIH HHS grantid: T32 CA111198 – fundername: NCI NIH HHS grantid: R01 CA109262-05 |
GroupedDBID | --- 2WC 3V. 53G 5VS 8G5 AADQD AAFWJ ABDBF ABUWG ACGFO ACIHN ADBBV ADRAZ AEAQA AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ CCPQU DIK DWQXO ESX GNUQQ GROUPED_DOAJ GUQSH GX1 HH5 HYE IPNFZ KQ8 M2O M48 MODMG M~E NPM OK1 P2P PGMZT PIMPY PQQKQ PROAC RIG RPM AAYXX CITATION 7XB 8FK MBDVC PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c469t-34f009dbc49205535d125d41e7712f1903684e1091f6fbe1e79c613e4aa9942a3 |
IEDL.DBID | RPM |
ISSN | 1424-8247 |
IngestDate | Tue Oct 22 15:15:26 EDT 2024 Tue Sep 17 21:11:36 EDT 2024 Sat Aug 17 03:13:07 EDT 2024 Thu Oct 10 17:21:32 EDT 2024 Fri Dec 06 01:18:34 EST 2024 Sat Sep 28 08:39:34 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | https://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c469t-34f009dbc49205535d125d41e7712f1903684e1091f6fbe1e79c613e4aa9942a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907906/ |
PMID | 20651945 |
PQID | 1525778411 |
PQPubID | 2032350 |
PageCount | 18 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_dcdc1ed70e3c4fd0b6ab7c20ef294fa0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2907906 proquest_miscellaneous_1835470398 proquest_journals_1525778411 crossref_primary_10_3390_ph3051576 pubmed_primary_20651945 |
PublicationCentury | 2000 |
PublicationDate | 20100518 |
PublicationDateYYYYMMDD | 2010-05-18 |
PublicationDate_xml | – month: 5 year: 2010 text: 20100518 day: 18 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Pharmaceuticals |
PublicationTitleAlternate | Pharmaceuticals (Basel) |
PublicationYear | 2010 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Alt (ref_98) 2003; 22 Martins (ref_91) 2006; 127 Kantarjian (ref_101) 2002; 346 ref_11 Zabludoff (ref_76) 2008; 7 Williams (ref_84) 2004; 67 Bond (ref_97) 2004; 119 Samoszuk (ref_107) 2003; 106 Maya (ref_50) 2001; 15 Bode (ref_21) 2004; 4 Huang (ref_23) 1999; 274 Faderl (ref_100) 1999; 341 Joensuu (ref_109) 2001; 344 Kruse (ref_12) 2009; 137 Gillespie (ref_85) 2004; 3 Millward (ref_87) 2006; 95 Goldberg (ref_83) 2008; 18 Chen (ref_7) 1993; 13 Shieh (ref_30) 2000; 14 Shvarts (ref_6) 1996; 15 Terzian (ref_93) 2007; 27 Gumireddy (ref_70) 2005; 102 Kharbanda (ref_55) 1995; 376 Savage (ref_99) 2002; 346 Higashimoto (ref_39) 2000; 275 Zhao (ref_78) 2006; 66 Shiloh (ref_17) 2003; 3 Yang (ref_49) 2004; 10 Prives (ref_20) 1998; 95 LeBron (ref_61) 2006; 25 Cheng (ref_51) 2009; 28 Kashishian (ref_77) 2003; 2 Okamoto (ref_60) 2005; 25 Hardcastle (ref_79) 2005; 48 Wang (ref_62) 2009; 16 Druker (ref_66) 1996; 2 Shafman (ref_54) 1997; 387 Chen (ref_64) 2005; 25 Vlahos (ref_80) 1994; 269 Kubbutat (ref_5) 1997; 387 Gorre (ref_105) 2001; 293 Haupt (ref_3) 1997; 387 Waterman (ref_27) 1998; 19 Vousden (ref_2) 2007; 8 Hickson (ref_71) 2004; 64 Zuckerman (ref_63) 2009; 284 Ventura (ref_92) 2007; 445 Arora (ref_104) 2005; 315 Dumaz (ref_38) 1999; 463 Dias (ref_56) 2006; 25 Froehner (ref_106) 2006; 58 Kastan (ref_16) 2004; 432 Blaydes (ref_22) 2001; 276 Goldberg (ref_57) 2002; 21 Mayo (ref_44) 1997; 57 Worrall (ref_45) 2010; 398 Zhang (ref_65) 2009; 9 Shinozaki (ref_52) 2003; 22 Toledo (ref_94) 2006; 6 Kawai (ref_48) 2003; 23 Knippschild (ref_40) 1997; 15 Pearson (ref_103) 2004; 4 Li (ref_25) 2004; 13 Kantarjian (ref_102) 2002; 8 Khosravi (ref_32) 1999; 96 Ashcroft (ref_33) 1999; 19 Chen (ref_58) 2005; 24 Santo (ref_75) 2010; 29 Kedei (ref_86) 2004; 64 Shieh (ref_29) 1997; 91 Hofmann (ref_42) 2002; 4 Oliner (ref_8) 1993; 362 Weisberg (ref_69) 2006; 94 Brasher (ref_53) 2000; 275 Vousden (ref_13) 2009; 137 Pereg (ref_59) 2006; 26 Bennett (ref_82) 2001; 98 Oliner (ref_95) 1992; 358 Noble (ref_90) 2004; 303 Meek (ref_19) 2009; 9 Jones (ref_96) 1998; 95 Buschmann (ref_41) 2001; 21 Chao (ref_31) 2003; 278 Das (ref_67) 2006; 49 Bartek (ref_35) 2001; 2 Rainey (ref_73) 2008; 68 Blattner (ref_46) 2002; 22 Cecchinelli (ref_43) 2002; 4 Kraft (ref_24) 2001; 20 Golding (ref_72) 2009; 8 Coward (ref_88) 2009; 5 Sakaguchi (ref_37) 2000; 275 Badciong (ref_14) 2002; 277 Basciani (ref_108) 2005; 65 Chernov (ref_28) 2001; 276 Tibbetts (ref_36) 1999; 13 Harris (ref_15) 2005; 24 Gatti (ref_26) 2000; 39 Ujiki (ref_89) 2006; 5 Sionov (ref_1) 1999; 18 Shah (ref_68) 2004; 305 Honda (ref_4) 1997; 420 Zhou (ref_18) 2000; 408 Hay (ref_10) 2000; 478 Dumaz (ref_34) 1999; 18 Momand (ref_9) 1992; 69 Hjerrild (ref_47) 2001; 355 Burris (ref_81) 2004; 9 Heath (ref_74) 2008; 26 |
References_xml | – volume: 10 start-page: 155 year: 2004 ident: ref_49 article-title: ATM and ATR: Sensing DNA damage publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v10.i2.155 contributor: fullname: Yang – volume: 22 start-page: 6170 year: 2002 ident: ref_46 article-title: Hypophosphorylation of Mdm2 augments p53 stability publication-title: Mol. Cell Biol. doi: 10.1128/MCB.22.17.6170-6182.2002 contributor: fullname: Blattner – volume: 277 start-page: 49668 year: 2002 ident: ref_14 article-title: MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination publication-title: J. Biol. Chem. doi: 10.1074/jbc.M208593200 contributor: fullname: Badciong – volume: 9 start-page: 714 year: 2009 ident: ref_19 article-title: Tumour suppression by p53: A role for the DNA damage response? publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2716 contributor: fullname: Meek – volume: 69 start-page: 1237 year: 1992 ident: ref_9 article-title: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation publication-title: Cell doi: 10.1016/0092-8674(92)90644-R contributor: fullname: Momand – volume: 9 start-page: 28 year: 2009 ident: ref_65 article-title: Targeting cancer with small molecule kinase inhibitors publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2559 contributor: fullname: Zhang – volume: 3 start-page: 1651 year: 2004 ident: ref_85 article-title: Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in melanoma cells publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.1651.3.12 contributor: fullname: Gillespie – volume: 68 start-page: 7466 year: 2008 ident: ref_73 article-title: Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-0763 contributor: fullname: Rainey – volume: 25 start-page: 6509 year: 2005 ident: ref_64 article-title: Regulation of p53-MDMX interaction by casein kinase 1 alpha publication-title: Mol. Cell Biol. doi: 10.1128/MCB.25.15.6509-6520.2005 contributor: fullname: Chen – volume: 48 start-page: 7829 year: 2005 ident: ref_79 article-title: Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach publication-title: J. Med. Chem. doi: 10.1021/jm050444b contributor: fullname: Hardcastle – volume: 58 start-page: 716 year: 2006 ident: ref_106 article-title: Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumor publication-title: Cancer Chemother. Pharmacol. doi: 10.1007/s00280-005-0181-6 contributor: fullname: Froehner – volume: 57 start-page: 5013 year: 1997 ident: ref_44 article-title: Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53 publication-title: Cancer Res. contributor: fullname: Mayo – volume: 22 start-page: 1442 year: 2003 ident: ref_98 article-title: Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis publication-title: EMBO J. doi: 10.1093/emboj/cdg133 contributor: fullname: Alt – volume: 14 start-page: 289 year: 2000 ident: ref_30 article-title: The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites publication-title: Genes. Dev. doi: 10.1101/gad.14.3.289 contributor: fullname: Shieh – volume: 275 start-page: 23199 year: 2000 ident: ref_39 article-title: Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents publication-title: J. Biol. Chem. doi: 10.1074/jbc.M002674200 contributor: fullname: Higashimoto – volume: 284 start-page: 4031 year: 2009 ident: ref_63 article-title: c-Abl phosphorylates Hdmx and regulates its interaction with p53 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M809211200 contributor: fullname: Zuckerman – volume: 25 start-page: 6666 year: 2006 ident: ref_56 article-title: c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF publication-title: Oncogene doi: 10.1038/sj.onc.1209671 contributor: fullname: Dias – volume: 5 start-page: 184 year: 2009 ident: ref_88 article-title: Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway publication-title: Autophagy doi: 10.4161/auto.5.2.7361 contributor: fullname: Coward – volume: 341 start-page: 164 year: 1999 ident: ref_100 article-title: The biology of chronic myeloid leukemia publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199907153410306 contributor: fullname: Faderl – volume: 3 start-page: 155 year: 2003 ident: ref_17 article-title: ATM and related protein kinases: safeguarding genome integrity publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1011 contributor: fullname: Shiloh – volume: 19 start-page: 1751 year: 1999 ident: ref_33 article-title: Regulation of p53 function and stability by phosphorylation publication-title: Mol. Cell Biol. doi: 10.1128/MCB.19.3.1751 contributor: fullname: Ashcroft – volume: 19 start-page: 175 year: 1998 ident: ref_27 article-title: ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins publication-title: Nat. Genet. doi: 10.1038/542 contributor: fullname: Waterman – volume: 24 start-page: 3411 year: 2005 ident: ref_58 article-title: ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage publication-title: EMBO J. doi: 10.1038/sj.emboj.7600812 contributor: fullname: Chen – volume: 15 start-page: 1727 year: 1997 ident: ref_40 article-title: p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs publication-title: Oncogene doi: 10.1038/sj.onc.1201541 contributor: fullname: Knippschild – volume: 64 start-page: 3243 year: 2004 ident: ref_86 article-title: Characterization of the interaction of ingenol 3-angelate with protein kinase C publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-03-3403 contributor: fullname: Kedei – volume: 27 start-page: 5479 year: 2007 ident: ref_93 article-title: Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.00555-06 contributor: fullname: Terzian – ident: ref_11 doi: 10.1016/j.semcancer.2009.10.005 – volume: 269 start-page: 5241 year: 1994 ident: ref_80 article-title: A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(17)37680-9 contributor: fullname: Vlahos – volume: 98 start-page: 13681 year: 2001 ident: ref_82 article-title: SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.251194298 contributor: fullname: Bennett – volume: 67 start-page: 2127 year: 2004 ident: ref_84 article-title: Meroterpenoid MAPKAP (MK2) inhibitors isolated from the indonesian marine sponge Acanthodendrilla sp publication-title: J. Nat. Prod. doi: 10.1021/np049808d contributor: fullname: Williams – volume: 387 start-page: 299 year: 1997 ident: ref_5 article-title: Regulation of p53 stability by Mdm2 publication-title: Nature doi: 10.1038/387299a0 contributor: fullname: Kubbutat – volume: 274 start-page: 12229 year: 1999 ident: ref_23 article-title: p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389 publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.18.12229 contributor: fullname: Huang – volume: 18 start-page: 6145 year: 1999 ident: ref_1 article-title: The cellular response to p53: The decision between life and death publication-title: Oncogene doi: 10.1038/sj.onc.1203130 contributor: fullname: Sionov – volume: 21 start-page: 3715 year: 2002 ident: ref_57 article-title: Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation publication-title: EMBO J. doi: 10.1093/emboj/cdf384 contributor: fullname: Goldberg – volume: 362 start-page: 857 year: 1993 ident: ref_8 article-title: Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 publication-title: Nature doi: 10.1038/362857a0 contributor: fullname: Oliner – volume: 15 start-page: 1067 year: 2001 ident: ref_50 article-title: ATM-dependent phosphorylation of Mdm2 on serine 395: Role in p53 activation by DNA damage publication-title: Genes Dev. doi: 10.1101/gad.886901 contributor: fullname: Maya – volume: 20 start-page: 1630 year: 2001 ident: ref_24 article-title: COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system publication-title: EMBO J. doi: 10.1093/emboj/20.7.1630 contributor: fullname: Kraft – volume: 315 start-page: 971 year: 2005 ident: ref_104 article-title: Role of tyrosine kinase inhibitors in cancer therapy publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.105.084145 contributor: fullname: Arora – volume: 7 start-page: 2955 year: 2008 ident: ref_76 article-title: AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-08-0492 contributor: fullname: Zabludoff – volume: 29 start-page: 2325 year: 2010 ident: ref_75 article-title: AT7519, a novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition publication-title: Oncogene doi: 10.1038/onc.2009.510 contributor: fullname: Santo – volume: 26 start-page: 59 year: 2008 ident: ref_74 article-title: A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors publication-title: Invest. New Drugs doi: 10.1007/s10637-007-9090-3 contributor: fullname: Heath – volume: 66 start-page: 5354 year: 2006 ident: ref_78 article-title: Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-05-4275 contributor: fullname: Zhao – volume: 2 start-page: 561 year: 1996 ident: ref_66 article-title: Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells publication-title: Nat. Med. doi: 10.1038/nm0596-561 contributor: fullname: Druker – volume: 463 start-page: 312 year: 1999 ident: ref_38 article-title: Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15 publication-title: FEBS Lett. doi: 10.1016/S0014-5793(99)01647-6 contributor: fullname: Dumaz – volume: 8 start-page: 275 year: 2007 ident: ref_2 article-title: p53 in health and disease publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm2147 contributor: fullname: Vousden – volume: 9 start-page: 10 year: 2004 ident: ref_81 article-title: Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib publication-title: Oncologist doi: 10.1634/theoncologist.9-suppl_3-10 contributor: fullname: Burris – volume: 4 start-page: 1 year: 2002 ident: ref_42 article-title: Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 publication-title: Nat. Cell Biol. doi: 10.1038/ncb715 contributor: fullname: Hofmann – volume: 13 start-page: 4107 year: 1993 ident: ref_7 article-title: Mapping of the p53 and mdm-2 interaction domains publication-title: Mol. Cell Biol. contributor: fullname: Chen – volume: 276 start-page: 4699 year: 2001 ident: ref_22 article-title: Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription publication-title: J. Biol. Chem. doi: 10.1074/jbc.M003485200 contributor: fullname: Blaydes – volume: 2 start-page: 1257 year: 2003 ident: ref_77 article-title: DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer publication-title: Mol. Cancer Ther. contributor: fullname: Kashishian – volume: 95 start-page: 15608 year: 1998 ident: ref_96 article-title: Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.95.26.15608 contributor: fullname: Jones – volume: 387 start-page: 520 year: 1997 ident: ref_54 article-title: Interaction between ATM protein and c-Abl in response to DNA damage publication-title: Nature doi: 10.1038/387520a0 contributor: fullname: Shafman – volume: 445 start-page: 661 year: 2007 ident: ref_92 article-title: Restoration of p53 function leads to tumour regression in vivo publication-title: Nature doi: 10.1038/nature05541 contributor: fullname: Ventura – volume: 4 start-page: 793 year: 2004 ident: ref_21 article-title: Post-translational modification of p53 in tumorigenesis publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1455 contributor: fullname: Bode – volume: 119 start-page: 591 year: 2004 ident: ref_97 article-title: A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans publication-title: Cell doi: 10.1016/j.cell.2004.11.022 contributor: fullname: Bond – volume: 65 start-page: 1897 year: 2005 ident: ref_108 article-title: Imatinib mesylate inhibits Leydig cell tumor growth: Evidence for in vitro and in vivo activity publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-04-2181 contributor: fullname: Basciani – volume: 303 start-page: 1800 year: 2004 ident: ref_90 article-title: Protein kinase inhibitors: insights into drug design from structure publication-title: Science doi: 10.1126/science.1095920 contributor: fullname: Noble – volume: 478 start-page: 183 year: 2000 ident: ref_10 article-title: Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains publication-title: FEBS Lett. doi: 10.1016/S0014-5793(00)01850-0 contributor: fullname: Hay – volume: 293 start-page: 876 year: 2001 ident: ref_105 article-title: Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification publication-title: Science doi: 10.1126/science.1062538 contributor: fullname: Gorre – volume: 432 start-page: 316 year: 2004 ident: ref_16 article-title: Cell-cycle checkpoints and cancer publication-title: Nature doi: 10.1038/nature03097 contributor: fullname: Kastan – volume: 26 start-page: 6819 year: 2006 ident: ref_59 article-title: Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage publication-title: Mol. Cell Biol. doi: 10.1128/MCB.00562-06 contributor: fullname: Pereg – volume: 127 start-page: 1323 year: 2006 ident: ref_91 article-title: Modeling the therapeutic efficacy of p53 restoration in tumors publication-title: Cell doi: 10.1016/j.cell.2006.12.007 contributor: fullname: Martins – volume: 4 start-page: 11 year: 2002 ident: ref_43 article-title: Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis publication-title: Nat. Cell Biol. doi: 10.1038/ncb714 contributor: fullname: Cecchinelli – volume: 23 start-page: 4939 year: 2003 ident: ref_48 article-title: Critical contribution of the MDM2 acidic domain to p53 ubiquitination publication-title: Mol. Cell Biol. doi: 10.1128/MCB.23.14.4939-4947.2003 contributor: fullname: Kawai – volume: 25 start-page: 1196 year: 2006 ident: ref_61 article-title: Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3 publication-title: EMBO J. doi: 10.1038/sj.emboj.7601032 contributor: fullname: LeBron – volume: 387 start-page: 296 year: 1997 ident: ref_3 article-title: Mdm2 promotes the rapid degradation of p53 publication-title: Nature doi: 10.1038/387296a0 contributor: fullname: Haupt – volume: 25 start-page: 9608 year: 2005 ident: ref_60 article-title: DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation publication-title: Mol. Cell Biol. doi: 10.1128/MCB.25.21.9608-9620.2005 contributor: fullname: Okamoto – volume: 94 start-page: 1765 year: 2006 ident: ref_69 article-title: AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6603170 contributor: fullname: Weisberg – volume: 278 start-page: 41028 year: 2003 ident: ref_31 article-title: Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses publication-title: J. Biol. Chem. doi: 10.1074/jbc.M306938200 contributor: fullname: Chao – volume: 13 start-page: 867 year: 2004 ident: ref_25 article-title: Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression publication-title: Mol. Cell doi: 10.1016/S1097-2765(04)00123-6 contributor: fullname: Li – volume: 106 start-page: 647 year: 2003 ident: ref_107 article-title: Acceleration of tumor growth and peri-tumoral blood clotting by imatinib mesylate (Gleevec) publication-title: Int. J. Cancer doi: 10.1002/ijc.11282 contributor: fullname: Samoszuk – volume: 39 start-page: 9837 year: 2000 ident: ref_26 article-title: Phosphorylation of human p53 on Thr-55 publication-title: Biochemistry doi: 10.1021/bi992454i contributor: fullname: Gatti – volume: 398 start-page: 414 year: 2010 ident: ref_45 article-title: The effects of phosphomimetic lid mutation on the thermostability of the N-terminal domain of MDM2 publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2010.03.023 contributor: fullname: Worrall – volume: 95 start-page: 829 year: 2006 ident: ref_87 article-title: The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6603331 contributor: fullname: Millward – volume: 305 start-page: 399 year: 2004 ident: ref_68 article-title: Overriding imatinib resistance with a novel ABL kinase inhibitor publication-title: Science doi: 10.1126/science.1099480 contributor: fullname: Shah – volume: 408 start-page: 433 year: 2000 ident: ref_18 article-title: The DNA damage response: Putting checkpoints in perspective publication-title: Nature doi: 10.1038/35044005 contributor: fullname: Zhou – volume: 4 start-page: 1113 year: 2004 ident: ref_103 article-title: Targeting protein kinases in cancer therapy: A success? publication-title: Expert Rev. Anticancer Ther. doi: 10.1586/14737140.4.6.1113 contributor: fullname: Pearson – volume: 275 start-page: 35631 year: 2000 ident: ref_53 article-title: c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines publication-title: J. Biol. Chem. doi: 10.1074/jbc.M005401200 contributor: fullname: Brasher – volume: 8 start-page: 2894 year: 2009 ident: ref_72 article-title: Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-09-0519 contributor: fullname: Golding – volume: 420 start-page: 25 year: 1997 ident: ref_4 article-title: Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 publication-title: FEBS Lett. doi: 10.1016/S0014-5793(97)01480-4 contributor: fullname: Honda – volume: 91 start-page: 325 year: 1997 ident: ref_29 article-title: DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 publication-title: Cell doi: 10.1016/S0092-8674(00)80416-X contributor: fullname: Shieh – volume: 344 start-page: 1052 year: 2001 ident: ref_109 article-title: Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200104053441404 contributor: fullname: Joensuu – volume: 49 start-page: 6819 year: 2006 ident: ref_67 article-title: 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor publication-title: J. Med. Chem. doi: 10.1021/jm060727j contributor: fullname: Das – volume: 15 start-page: 5349 year: 1996 ident: ref_6 article-title: MDMX: A novel p53-binding protein with some functional properties of MDM2 publication-title: EMBO J. doi: 10.1002/j.1460-2075.1996.tb00919.x contributor: fullname: Shvarts – volume: 2 start-page: 877 year: 2001 ident: ref_35 article-title: CHK2 kinase—A busy messenger publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/35103059 contributor: fullname: Bartek – volume: 21 start-page: 2743 year: 2001 ident: ref_41 article-title: Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress publication-title: Mol. Cell Biol. doi: 10.1128/MCB.21.8.2743-2754.2001 contributor: fullname: Buschmann – volume: 137 start-page: 413 year: 2009 ident: ref_13 article-title: Blinded by the Light: The Growing Complexity of p53 publication-title: Cell doi: 10.1016/j.cell.2009.04.037 contributor: fullname: Vousden – volume: 6 start-page: 909 year: 2006 ident: ref_94 article-title: Regulating the p53 pathway: In vitro hypotheses, in vivo veritas publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2012 contributor: fullname: Toledo – volume: 96 start-page: 14973 year: 1999 ident: ref_32 article-title: Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.96.26.14973 contributor: fullname: Khosravi – volume: 64 start-page: 9152 year: 2004 ident: ref_71 article-title: Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-04-2727 contributor: fullname: Hickson – volume: 355 start-page: 347 year: 2001 ident: ref_47 article-title: Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells publication-title: Biochem. J. doi: 10.1042/bj3550347 contributor: fullname: Hjerrild – volume: 346 start-page: 645 year: 2002 ident: ref_101 article-title: Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa011573 contributor: fullname: Kantarjian – volume: 28 start-page: 3857 year: 2009 ident: ref_51 article-title: ATM activates p53 by regulating MDM2 oligomerization and E3 processivity publication-title: EMBO J. doi: 10.1038/emboj.2009.294 contributor: fullname: Cheng – volume: 18 start-page: 938 year: 2008 ident: ref_83 article-title: Pyrazinoindolone inhibitors of MAPKAP-K2 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2007.12.037 contributor: fullname: Goldberg – volume: 275 start-page: 9278 year: 2000 ident: ref_37 article-title: Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase: Effect on Mdm2 binding publication-title: J. Biol. Chem. doi: 10.1074/jbc.275.13.9278 contributor: fullname: Sakaguchi – volume: 276 start-page: 31819 year: 2001 ident: ref_28 article-title: Regulation of ubiquitination and degradation of p53 in unstressed cells through C-terminal phosphorylation publication-title: J. Biol. Chem. doi: 10.1074/jbc.M103170200 contributor: fullname: Chernov – volume: 102 start-page: 1992 year: 2005 ident: ref_70 article-title: A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0408283102 contributor: fullname: Gumireddy – volume: 95 start-page: 5 year: 1998 ident: ref_20 article-title: Signaling to p53: Breaking the MDM2-p53 circuit publication-title: Cell doi: 10.1016/S0092-8674(00)81774-2 contributor: fullname: Prives – volume: 358 start-page: 80 year: 1992 ident: ref_95 article-title: Amplification of a gene encoding a p53-associated protein in human sarcomas publication-title: Nature doi: 10.1038/358080a0 contributor: fullname: Oliner – volume: 8 start-page: 2177 year: 2002 ident: ref_102 article-title: Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: Follow-up results publication-title: Clin. Cancer Res. contributor: fullname: Kantarjian – volume: 346 start-page: 683 year: 2002 ident: ref_99 article-title: Imatinib mesylate—A new oral targeted therapy publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra013339 contributor: fullname: Savage – volume: 137 start-page: 609 year: 2009 ident: ref_12 article-title: Modes of p53 regulation publication-title: Cell doi: 10.1016/j.cell.2009.04.050 contributor: fullname: Kruse – volume: 5 start-page: 76 year: 2006 ident: ref_89 article-title: Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest publication-title: Mol. Cancer doi: 10.1186/1476-4598-5-76 contributor: fullname: Ujiki – volume: 13 start-page: 152 year: 1999 ident: ref_36 article-title: A role for ATR in the DNA damage-induced phosphorylation of p53 publication-title: Genes. Dev. doi: 10.1101/gad.13.2.152 contributor: fullname: Tibbetts – volume: 18 start-page: 7002 year: 1999 ident: ref_34 article-title: Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2 publication-title: EMBO J. doi: 10.1093/emboj/18.24.7002 contributor: fullname: Dumaz – volume: 16 start-page: 33 year: 2009 ident: ref_62 article-title: Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.05.008 contributor: fullname: Wang – volume: 22 start-page: 8870 year: 2003 ident: ref_52 article-title: Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export publication-title: Oncogene doi: 10.1038/sj.onc.1207176 contributor: fullname: Shinozaki – volume: 376 start-page: 785 year: 1995 ident: ref_55 article-title: Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents publication-title: Nature doi: 10.1038/376785a0 contributor: fullname: Kharbanda – volume: 24 start-page: 2899 year: 2005 ident: ref_15 article-title: The p53 pathway: positive and negative feedback loops publication-title: Oncogene doi: 10.1038/sj.onc.1208615 contributor: fullname: Harris |
SSID | ssj0057141 |
Score | 2.0100129 |
Snippet | The p53 tumor suppressor is a key protein in maintaining the integrity of the genome by inducing either cell cycle arrest or apoptosis following cellular... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1576 |
SubjectTerms | kinase inhibitor Mdm2 Mdmx p53 phosphorylation Review |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07TyMxEB4hqmsQcAcsL-2dgAqL9Wu9LrkIhE4CUYBEt_JTpGCJQiLBv2ccJyE5IdHQbGG7mJ1Ze75Zz3wDcMQRRdTWa8KZ8URw64iRghIuGmucCY66dKN7fVNf3Yt_D_JhodVXygnL9MBZcWfeeUeDV1XgTkRf2dpY5VgVItMimhytV2wWTOUzWKrcszKVcZGGCZU5hTgG-GeDR576miSSkQVPNCHs_wxl_p8sueB9LtdhbQoby_Ms7gashG4TTm4z7_TbaXn3UUb1clqelLcfjNRvP-G4lxPSU-l5iYivvPZPjODjlQwkL3v9oRv3R7_g_vLirndFpv0RiMOgdoT6jIiQvHVCs0pKLj2iFS9oUIqyiJ6e140Iifkz1tEGHNcOvXcQxmgtmOFbsNo9d2EHyhiiNThWBxqFNImUXhkMnurYaBdFKODPTFftINNgtBg-JIW2c4UW8Ddpcb4gMVdPBtCe7dSe7Vf2LGB_ZoN2up1e2tSkSaUbUlrA7_k0boR0u2G68DzGNekXFp5fuilgO5tsLglDoEW1kAWoJWMuibo80_UfJ2TbTFdKV_Xud7zbHvyYJR_QZh9WR8NxOEBMM7KHk8_3HXbH9RY priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB61y6U9lT5TaJVWLScs4lccn5BYgVAl0KoCiVvkZ9kD2e0-pPLvGW-SXbZCXHKwfbDG8cw3D38D8IMjiiit14Qz44ng1hEjBSVcVNY4Exx1KaN7cVmeX4tfN_KmC7jNu7LKXieuFLWfuBQjP0p9elRKktHj6V-Sukal7GrXQuMl7DDKq2oAOyenl6PfvS6Wigra8glxdO6Pprc89TRJBCOPrNCKrP8phPl_oeQjy3P2Bl6n1wh5G8LfhReheQsHo5Zv-v4wv9o8n5of5gf5aMNEff8Ofg7bQvT05DxHpJdf-DtG8POPTCXPh-OZW44X7-H67PRqeE66vgjEoTO7QDlGREbeOqFZISWXHlGKFzQoRVlEC8_LSoTE-BnLaAOOa4dWOwhjtBbM8A8waCZN-AR5DNEaHCsDjUKaREavDDpNZay0iyJk8L2XUz1t6S9qdBuSMOu1MDM4SRJcL0iM1auByexP3V2A2jvvaPCqCNyJ6AtbGqscK0JkWkRTZLDfy7_urtG83hx6Bt_W03gBUlbDNGGyxDUpdIV6S1cZfGyPa70ThgCLaiEzUFsHubXV7ZlmfLsi2Wa6ULooPz-_rT141ZcT0GofBovZMnxBlLKwX7tf8QH8ZuhM priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwEB6VcuGCoLwCBQUEPdWQ-BkfEGpXVBXSoh66Um-Rn-1KkF22u1L33zPebFJSlUsOthNZM3bmG8_4G4CPDFGEtF4TRo0nnFlHjOAlYbyyxpngSpciuuOf8nTCf1yIix3oamxuBXh9r2uX6klNFr8-3_xZf8MN_zV5nOiyf5lfsVSpRMkH8JCiQUyZXWPeBxOEagtYpjtdpKJctQRDw1cTKTBaY3TpxcBCbYj870Ofd5Mo_7FKJ0_g8RZO5ket_p_CTmj24OCs5aNeH-bnt9errg_zg_zslql6_Qw-jdpE9XQlPUckmI_9b0rwcUPmguWj6cKtpsvnMDn5fj46Jdu6CcShs7tEOUdETt46rmkhBBMeUYznZVCqpBERAJMVD4kRNMpoA7Zrh1Y9cGO05tSwF7DbzJrwCvIYojXYJkMZuTCJrF4ZdKpkrLSLPGTwoZNVPW_pMWp0K5Js6162GRwnKfYDEqP1pmG2uKy3G6T2zrsyeFUE5nj0hZXGKkeLEKnm0RQZ7Hc6qLtVUqfiTSpFTssM3vfduEFS1MM0YbbCMeloC_9rusrgZauyfiadyjNQA2UOpjrsaaZXGxJuqgulC_n6v998A4-6TIOy2ofd5WIV3iKAWdp3m-X5FyZu69s priority: 102 providerName: Scholars Portal |
Title | Controlling the Mdm2-Mdmx-p53 Circuit |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20651945 https://www.proquest.com/docview/1525778411 https://search.proquest.com/docview/1835470398 https://pubmed.ncbi.nlm.nih.gov/PMC2907906 https://doaj.org/article/dcdc1ed70e3c4fd0b6ab7c20ef294fa0 |
Volume | 3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEB7yuPRS2qaPbVOzKW1O2Xj1Wq2OjUkIAQdTEsht0bMxxGvj2ND8-4724dSlp1500APEjKSZTxp9A_CVoRdRGKcyRrXLODM204KTjPHSaKu9JTa-6I6vi8tbfnUn7nZA9H9hmqB9a6an9cPstJ7eN7GVi5kd9nFiw8l4RBHRqbwY7sIumt8eorfHr5CEk5ZCiCGeHy7uWUxjImOuIor2FkG72LJBDVX_v_zLv8Mk_7A7F6_gZecwpt_bib2GHV-_geNJyzj9dJLePH-gejxJj9PJMxf10wF8G7Wh6PHTeYq-Xjp2M5ph8StbCJaOpku7nq7ewu3F-c3oMusyI2QW4ewKJRnQN3LGckVzIZhw6Kc4TryUhAa08awouY-cn6EIxmO9smi3PddaKU41ewd79bz2HyANPhiNdYUngQsd6eilRthUhFLZwH0CX3pZVYuWAKNC4BBlW21km8BZlOKmQ-Ssbirmy59Vp7nKWWeJdzL3zPLgclNoIy3NfaCKB50ncNjroOo20mMV0zPJ-DZKEjjaNOMWiO8auvbzNfaJl1d4cqkygfetyjYz6VWegNxS5tZUt1tw1TU0290q-_jfIz_Biz7WgJSHsLdarv1ndGFWZgD7Z-fXkx-D5goAyzEvB80y_g0cAfTv |
link.rule.ids | 230,313,314,727,780,784,792,864,885,2102,2221,21388,24318,27922,27924,27925,33744,33745,43805,53791,53793,74302 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEB5BegBOvDEUMAh6qlXvy-s9ITVqFaCJIpRKvVn7bHPACXlI9N8zG9tJgxAXH3b3sJr1znzz2G8APjFEEYVxKmNUu4wzYzMtOMkYL4222ltiY0Z3OCoGl_zblbhqA27Ltqyy04kbRe1mNsbIT2KfHhmTZOTL_FcWu0bF7GrbQuM-HETmdNGDg9Oz0fhHp4uFJJw0fEIMnfuT-Q2LPU0iwcgdK7Qh6_8Xwvy7UPKO5Tl_DI_ia4S0CeE_gXu-fgpH44Zv-vY4neyeTy2P06N0vGOivn0Gn_tNIXp8cp4i0kuH7ifN8PM7mwuW9qcLu56unsPl-dmkP8javgiZRWd2hXIMiIycsVzRXAgmHKIUx4mXktCAFp4VJfeR8TMUwXgcVxattudaK8WpZi-gV89q_wrS4IPROFZ4ErjQkYxeanSailAqG7hP4GMnp2re0F9U6DZEYVZbYSZwGiW4XRAZqzcDs8V11V6AyllniXcy98zy4HJTaCMtzX2gigedJ3DYyb9qr9Gy2h16Ah-203gBYlZD1362xjUxdIV6S5UJvGyOa7sTigCLKC4SkHsHubfV_Zl6erMh2aYqlyovXv9_W-_hwWAyvKguvo6-v4GHXWkBKQ-ht1qs_VtELCvzrv0t_wD6qes0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxEB5BKiE48e62BRYEPXWV9Wu9PiE1NCqPRhFqpd5WftIc2IQ8JPrvGWd3kwYhLj7YPlhje-Ybz_gbgPcMUURhnMoY1S7jzNhMC04yxkujrfaW2BjRvRgV51f8y7W4bvOfFm1aZacT14raTW18I-_HOj0yBslIP7RpEeNPw4-zX1msIBUjrW05jfuwh1Yxpz3YOz0bjb93ellIwknDLcTQ0e_PblisbxLJRu5YpDVx_7_Q5t9Jk3es0PAxPIo_E9LmOf8J3PP1UzgeN9zTtyfp5fYr1eIkPU7HW1bq22fwYdAkpcfv5ymivvTC_aQZNr-zmWDpYDK3q8nyOVwNzy4H51lbIyGz6NguUaYBUZIzliuaC8GEQ8TiOPFSEhrQ2rOi5D6yf4YiGI_9yqIF91xrpTjV7AX06mnt9yENPhiNfYUngQsdiemlRgeqCKWygfsE3nVyqmYNFUaFLkQUZrURZgKnUYKbCZG9et0xnf-o2stQOess8U7mnlkeXG4KbaSluQ9U8aDzBI46-VftlVpU2wOQwNvNMF6GGOHQtZ-ucE58xkIdpsoEXjbbtVkJRbBFFBcJyJ2N3Fnq7kg9uVkTblOVS5UXB_9f1ht4gCey-vZ59PUQHnZZBqQ8gt5yvvKvELwszev2VP4B0D3vYQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Controlling+the+Mdm2-Mdmx-p53+Circuit&rft.jtitle=Pharmaceuticals&rft.au=Waning%2C+David+L&rft.au=Lehman%2C+Jason+A&rft.au=Batuello%2C+Christopher+N&rft.au=Mayo%2C+Lindsey+D&rft.date=2010-05-18&rft.pub=MDPI+AG&rft.eissn=1424-8247&rft.volume=3&rft.issue=5&rft.spage=1576&rft_id=info:doi/10.3390%2Fph3051576&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3307079151 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1424-8247&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1424-8247&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1424-8247&client=summon |